XPEV vs. TMDX
XPEV (XPeng Inc.) and TMDX (TransMedics Group, Inc.) are both stocks. XPEV operates in Auto Manufacturers (Consumer Cyclical), while TMDX operates in Medical Devices (Healthcare). Over the past 5 years, XPEV returned -18.98%/yr vs 20.83%/yr for TMDX. At a 0.24 correlation, their price movements are largely independent.
Performance
XPEV vs. TMDX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XPEV achieves a -28.55% return, which is significantly higher than TMDX's -40.07% return.
XPEV
- 1D
- 0.21%
- 1M
- -7.23%
- YTD
- -28.55%
- 6M
- -23.70%
- 1Y
- -20.30%
- 3Y*
- 12.09%
- 5Y*
- -18.98%
- 10Y*
- —
TMDX
- 1D
- -0.92%
- 1M
- 15.36%
- YTD
- -40.07%
- 6M
- -42.50%
- 1Y
- -48.97%
- 3Y*
- -4.58%
- 5Y*
- 20.83%
- 10Y*
- —
XPEV vs. TMDX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
XPEV XPeng Inc. | -28.55% | 71.57% | -18.99% | 46.78% | -80.25% | 17.51% | 85.41% |
TMDX TransMedics Group, Inc. | -40.07% | 95.11% | -21.01% | 27.88% | 222.13% | -3.72% | 11.48% |
Correlation
The correlation between XPEV and TMDX is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since Aug 27, 2020 | 0.24 |
The correlation between XPEV and TMDX shifts across timeframes, from 0.14 (3 years) to 0.24 (all time), reflecting how their relationship changes across market environments.
Fundamentals
XPEV:
$6.92B
TMDX:
$2.64B
XPEV:
-CN¥3.15
TMDX:
$4.34
XPEV:
0.95
TMDX:
4.54
XPEV:
1.65
TMDX:
5.34
XPEV:
CN¥73.56B
TMDX:
$635.89M
XPEV:
CN¥14.61B
TMDX:
$375.74M
XPEV:
-CN¥3.76B
TMDX:
$125.51M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XPEV vs. TMDX — Risk / Return Rank
XPEV
TMDX
XPEV vs. TMDX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for XPeng Inc. (XPEV) and TransMedics Group, Inc. (TMDX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XPEV | TMDX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.40 | ||
| Sortino ratioReturn per unit of downside risk | +0.80 | ||
| Omega ratioGain probability vs. loss probability | 0.96 | 0.86 | +0.10 |
| Calmar ratioReturn relative to maximum drawdown | -0.51 | -0.84 | +0.33 |
| Martin ratioReturn relative to average drawdown | -0.89 | -1.99 | +1.10 |
Loading charts...
Drawdowns
XPEV vs. TMDX - Drawdown Comparison
The maximum XPEV drawdown since its inception was -91.12%, which is greater than TMDX's maximum drawdown of -73.69%. Use the drawdown chart below to compare losses from any high point for XPEV and TMDX.
Loading charts...
Drawdown Indicators
| XPEV | TMDX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -91.12% | -73.69% | -17.43% |
Max Drawdown (1Y)Largest decline over 1 year | -48.49% | -58.76% | +10.27% |
Max Drawdown (3Y)Largest decline over 3 years | -71.65% | -67.79% | -3.86% |
Max Drawdown (5Y)Largest decline over 5 years | -88.35% | -67.79% | -20.56% |
Current DrawdownCurrent decline from peak | -79.92% | -58.60% | -21.32% |
Average DrawdownAverage peak-to-trough decline | -67.89% | -31.89% | -36.00% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 27.68% | 24.65% | +3.03% |
Volatility
XPEV vs. TMDX - Volatility Comparison
XPeng Inc. (XPEV) has a higher volatility of 14.02% compared to TransMedics Group, Inc. (TMDX) at 12.66%. This indicates that XPEV's price experiences larger fluctuations and is considered to be riskier than TMDX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XPEV | TMDX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.02% | 12.66% | +1.36% |
Volatility (6M)Calculated over the trailing 6-month period | 35.62% | 43.87% | -8.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 55.48% | 58.06% | -2.58% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 78.68% | 72.00% | +6.68% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 83.39% | 71.72% | +11.67% |
Dividends
XPEV vs. TMDX - Dividend Comparison
Neither XPEV nor TMDX has paid dividends to shareholders.
Financials
XPEV vs. TMDX - Financials Comparison
This section allows you to compare key financial metrics between XPeng Inc. and TransMedics Group, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
XPEV vs. TMDX - Profitability Comparison
XPEV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, XPeng Inc. reported a gross profit of 2.67B and revenue of 12.95B. Therefore, the gross margin over that period was 20.6%.
TMDX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, TransMedics Group, Inc. reported a gross profit of 101.16M and revenue of 173.93M. Therefore, the gross margin over that period was 58.2%.
XPEV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, XPeng Inc. reported an operating income of -2.10B and revenue of 12.95B, resulting in an operating margin of -16.2%.
TMDX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, TransMedics Group, Inc. reported an operating income of 13.30M and revenue of 173.93M, resulting in an operating margin of 7.6%.
XPEV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, XPeng Inc. reported a net income of -1.77B and revenue of 12.95B, resulting in a net margin of -13.7%.
TMDX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, TransMedics Group, Inc. reported a net income of 7.32M and revenue of 173.93M, resulting in a net margin of 4.2%.
Frequently Asked Questions
XPEV and TMDX have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XPEV has higher volatility (14.02%) compared to TMDX (12.66%). In terms of maximum drawdown, XPEV dropped -91.12% vs TMDX's -73.69%.
XPEV currently has the higher Sharpe Ratio (-0.45 vs -0.85), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XPEV and TMDX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer